FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1986
NDA30/100
INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
calcium chloride; dextrose; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1986
NDA30/100
INSPRA
eplerenone
LOE Approaching
Viatris (2)
ORAL · TABLET
2002
NDA30/100
INTAL
cromolyn sodium
LOE Approaching
Pfizer
INHALATION · AEROSOL, METERED
1985
NDA30/100
INTAL
cromolyn sodium
LOE Approaching
Pfizer
INHALATION · SOLUTION
1982
NDA30/100
INTEGRILIN
eptifibatide
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1998
PeptideNDA30/100
INTELENCE
etravirine
LOE Approaching
Johnson & Johnson
ORAL · TABLET
2008
NDA30/100
INTRALIPID 10%
i.v. fat emulsion
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
1975
NDA30/100
INTRALIPID 20%
i.v. fat emulsion
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
1981
NDA30/100
INTRALIPID 20%
i.v. fat emulsion
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
1996
NDA30/100
INTRALIPID 30%
i. v. fat emulsion
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
1993
NDA30/100
INTROPIN
dopamine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1974
NDA30/100
INTUNIV
guanfacine
LOE Approaching
Takeda
ORAL · TABLET, EXTENDED RELEASE
Attention Deficit Hyperactivity Disorder (ADHD)adjunctive therapy to stimulant medications (,)
2009
NDA30/100
INULIN AND SODIUM CHLORIDE
inulin
LOE Approaching
INJECTION · INJECTABLE
1940
NDA30/100
INVANZ
ertapenem sodium
LOE Approaching
Merck & Co.
INTRAMUSCULAR, INTRAVENOUS · INJECTABLE
older) with complicated intra-abdominal infections due to Escherichia coliClostridium clostridioforme+25
2001
NDA30/100
INVEGA
paliperidone
LOE Approaching
Johnson & Johnson
ORAL · TABLET, EXTENDED RELEASE
schizoaffective disorderSchizophrenia
2006
NDA30/100
INVEGA
paliperidone
LOE Approaching
Johnson & Johnson
ORAL · TABLET, EXTENDED RELEASE
2007
NDA30/100
INVERSINE
mecamylamine hydrochloride
LOE Approaching
ORAL · TABLET
1956
NDA30/100
INVIRASE
saquinavir mesylate
LOE Approaching
Roche
ORAL · CAPSULE
1995
NDA30/100
INVIRASE
saquinavir mesylate
LOE Approaching
Roche
ORAL · TABLET
2004
NDA30/100
IOBENGUANE SULFATE I 131
iobenguane sulfate i-131
LOE Approaching
PharmaLundensis
INJECTION · INJECTABLE
1994
NDA30/100
IODOTOPE
sodium iodide i-131
LOE Approaching
Bracco
ORAL · CAPSULE
1957
NDA30/100
IONAMIN
phentermine resin complex
LOE Approaching
UCB Pharma
ORAL · CAPSULE, EXTENDED RELEASE
1959
NDA30/100
IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER
dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride; sodium lactate; sodium phosphate, monobasic anhydrous
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1986
NDA30/100